Rouanet P - Search Results

1

Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.

Mangé A, Lacombe J, Bascoul-Mollevi C, Jarlier M, Lamy PJ, Rouanet P, Maudelonde T, Solassol J. Mangé A, et al. Among authors: rouanet p. Clin Cancer Res. 2012 Apr 1;18(7):1992-2000. doi: 10.1158/1078-0432.CCR-11-2527. Epub 2012 Feb 9. Clin Cancer Res. 2012. PMID: 22322670

2

Correlation between mannose-6-phosphate/IGFII receptor and cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumors.

Zhao Y, Escot C, Maudelonde T, Puech C, Rouanet P, Rochefort H. Zhao Y, et al. Among authors: rouanet p. Cancer Res. 1993 Jun 15;53(12):2901-5. Cancer Res. 1993. PMID: 7684951

3

In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer.

Maudelonde T, Escot C, Pujol P, Rouanet P, Defrenne A, Brouillet JP, Rochefort H. Maudelonde T, et al. Among authors: rouanet p. Eur J Cancer. 1994;30A(14):2049-53. doi: 10.1016/0959-8049(94)00343-4. Eur J Cancer. 1994. PMID: 7857701

4

A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol.

Pujol P, Maudelonde T, Daures JP, Rouanet P, Brouillet JP, Pujol H, Rochefort H. Pujol P, et al. Among authors: rouanet p. Cancer. 1993 Mar 15;71(6):2006-12. doi: 10.1002/1097-0142(19930315)71:6<2006::aid-cncr2820710614>3.0.co;2-q. Cancer. 1993. PMID: 8443752

5

Neoadjuvant tamoxifen for operable breast cancer: a need for phase III studies?

Pujol P, Daures JP, Rouanet P, Hermand J, Domergue J, Grenier J, Maudelonde T. Pujol P, et al. Among authors: rouanet p. Cancer Detect Prev. 2000;24(5):445-51. Cancer Detect Prev. 2000. PMID: 11129986 Clinical Trial.

6

A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.

Pujol P, Daures JP, Brouillet JP, Chang S, Rouanet P, Bringer J, Grenier J, Maudelonde T. Pujol P, et al. Among authors: rouanet p. Cancer. 2001 May 15;91(10):1854-61. Cancer. 2001. PMID: 11346866

7

Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy.

Lamy PJ, Pujol P, Thezenas S, Kramar A, Rouanet P, Guilleux F, Grenier J. Lamy PJ, et al. Among authors: rouanet p. Breast Cancer Res Treat. 2002 Nov;76(1):65-71. doi: 10.1023/a:1020228620173. Breast Cancer Res Treat. 2002. PMID: 12408377

8

Spontaneous apoptosis in the intra-ductal component's stroma of breast invasive carcinoma.

Rouleau-Dubois C, Cuny M, Ferrieres G, Simony-Lafontaine J, Rouanet P, Grenier J, Jeanteur P, Baldet P, Escot C. Rouleau-Dubois C, et al. Among authors: rouanet p. Anticancer Res. 2004 Jan-Feb;24(1):53-7. Anticancer Res. 2004. PMID: 15015575 Free article.

9

Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection.

Solassol J, Marin P, Demettre E, Rouanet P, Bockaert J, Maudelonde T, Mangé A. Solassol J, et al. Among authors: rouanet p. Anal Biochem. 2005 Mar 1;338(1):26-31. doi: 10.1016/j.ab.2004.11.031. Anal Biochem. 2005. PMID: 15707932

10

Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.

Rouanet P, Linares-Cruz G, Dravet F, Poujol S, Gourgou S, Simony-Lafontaine J, Grenier J, Kramar A, Girault J, Le Nestour E, Maudelonde T. Rouanet P, et al. J Clin Oncol. 2005 May 1;23(13):2980-7. doi: 10.1200/JCO.2005.06.064. J Clin Oncol. 2005. PMID: 15860853 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters